Understanding market access starts with understanding the market

We have extensive experience navigating the complex landscape of market access questions

Market access is a highly sensitive process that requires nuanced understanding of the therapeutic area, knowledge about local market conditions, and flexibility to address evolving market-specific needs. We have experience applying our analytic skills to paint a nuanced picture of a market to facilitate a strong understanding of opportunities and threats. We use this strong analytic foundation to partner with our clients in achieving their strategic goals, across markets and across the world.

Our areas of expertise include:

  • Dossier preparation to support country-specific HTA and reimbursement submissions
  • Organizing and moderating payer panels and advisory boards to identify access controls on current and future markets within a therapeutic area and to understand value drivers
  • High-quality situational analyses of markets
  • Quantitative pricing analyses
  • Valuing clinical trial endpoints
  • Consultation on launch strategy
  • Consultation in emerging markets HEOR and market access strategy